These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 15372259)
1. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. Achiron A; Kishner I; Dolev M; Stern Y; Dulitzky M; Schiff E; Achiron R J Neurol; 2004 Sep; 251(9):1133-7. PubMed ID: 15372259 [TBL] [Abstract][Full Text] [Related]
2. The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with multiple sclerosis. Brandt-Wouters E; Gerlach OH; Hupperts RM Int J Gynaecol Obstet; 2016 Aug; 134(2):194-6. PubMed ID: 27177509 [TBL] [Abstract][Full Text] [Related]
3. A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis. Haas J; Hommes OR Mult Scler; 2007 Aug; 13(7):900-8. PubMed ID: 17881400 [TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulins for the prevention of postpartum relapses in multiple sclerosis. Horvat Ledinek A; Brecl Jakob G; Jerše J; Ruška B; Pavičić T; Gabelić T; Barun B; Adamec I; Rot U; Šega Jazbec S; Krbot Skorić M; Habek M Mult Scler Relat Disord; 2020 Feb; 38():101519. PubMed ID: 31756610 [TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin treatment in multiple sclerosis: A prospective, rater-blinded analysis of relapse rates during pregnancy and the postnatal period. Winkelmann A; Rommer PS; Hecker M; Zettl UK CNS Neurosci Ther; 2019 Jan; 25(1):78-85. PubMed ID: 29858532 [TBL] [Abstract][Full Text] [Related]
8. Long term safety of IVIg therapy in multiple sclerosis: 10 years experience. Katz U; Kishner I; Magalashvili D; Shoenfeld Y; Achiron A Autoimmunity; 2006 Sep; 39(6):513-7. PubMed ID: 17060031 [TBL] [Abstract][Full Text] [Related]
9. Pregnancy in Multiple Sclerosis: A Portuguese cohort study. Jesus-Ribeiro J; Correia I; Martins AI; Fonseca M; Marques I; Batista S; Nunes C; Macário C; Almeida MC; Sousa L Mult Scler Relat Disord; 2017 Oct; 17():63-68. PubMed ID: 29055477 [TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis. Dudesek A; Zettl UK J Neurol; 2006 Sep; 253 Suppl 5():V50-8. PubMed ID: 16998754 [TBL] [Abstract][Full Text] [Related]
11. High dose IVIG in the post partum period for prevention of exacerbations in MS. Haas J Mult Scler; 2000 Oct; 6 Suppl 2():S18-20; discussion S33. PubMed ID: 11188773 [TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin treatment in the prevention of childbirth-associated acute exacerbations in multiple sclerosis: a pilot study. Achiron A; Rotstein Z; Noy S; Mashiach S; Dulitzky M; Achiron R J Neurol; 1996 Jan; 243(1):25-8. PubMed ID: 8869383 [TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial. Fazekas F; Lublin FD; Li D; Freedman MS; Hartung HP; Rieckmann P; Sørensen PS; Maas-Enriquez M; Sommerauer B; Hanna K; ; Neurology; 2008 Jul; 71(4):265-71. PubMed ID: 18645164 [TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses. Achiron A; Gabbay U; Gilad R; Hassin-Baer S; Barak Y; Gornish M; Elizur A; Goldhammer Y; Sarova-Pinhas I Neurology; 1998 Feb; 50(2):398-402. PubMed ID: 9484361 [TBL] [Abstract][Full Text] [Related]
16. A double-blind, cross-over trial of intravenous immunoglobulin G in multiple sclerosis: preliminary results. Sørensen PS; Wanscher B; Schreiber K; Blinkenberg M; Jensen CV; Ravnborg M Mult Scler; 1997 Apr; 3(2):145-8. PubMed ID: 9291170 [TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss. Banjar S; Kadour E; Khoudja R; Ton-Leclerc S; Beauchamp C; Beltempo M; Dahan MH; Gold P; Jacques Kadoch I; Jamal W; Laskin C; Mahutte N; Reinblatt SL; Sylvestre C; Buckett W; Genest G Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929 [TBL] [Abstract][Full Text] [Related]
18. Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis. de Seze J; Chapelotte M; Delalande S; Ferriby D; Stojkovic T; Vermersch P Mult Scler; 2004 Oct; 10(5):596-7. PubMed ID: 15471379 [TBL] [Abstract][Full Text] [Related]
19. Intravenous polyclonal human immunoglobulins in multiple sclerosis. Soelberg Sorensen P Neurodegener Dis; 2008; 5(1):8-15. PubMed ID: 18075269 [TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis. Sorensen PS; Wanscher B; Jensen CV; Schreiber K; Blinkenberg M; Ravnborg M; Kirsmeier H; Larsen VA; Lee ML Neurology; 1998 May; 50(5):1273-81. PubMed ID: 9595974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]